Shine-On BioMedical ,Ltd. EBIT

As of the most recent data (June 2026), 6926.TWO shows a EBIT of $-320M. That compares with $-130M in the prior-year period — down 148.4% year over year. That is below the Healthcare sector average of $130B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6926.TWO's EBIT is now $-320M (was $-130M) — a 148.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shine-On BioMedical ,Ltd. is outperforming or lagging.

The Healthcare sector average EBIT is about $130B. Shine-On BioMedical ,Ltd. is at $-320M, which is lower that average. That is roughly 100.2% below the sector mean. Use the comparison chart on this page to see how 6926.TWO stacks up against individual peers as well.

Tracking 6926.TWO's ebit over time shows whether Shine-On BioMedical ,Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $-320M That compares with $-130M in the prior-year period — down 148.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Shine-On BioMedical ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-320M) with ownership activity and broader fundamentals.